MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Orthostatic hypotension(OH)"

  • 2016 International Congress

    Cognitive and behavioral side effects in patients treated with droxidopa for neurogenic orthostatic hypotension

    K.E. McDonell, C.A. Shibao, I. Biagginoi, D. Robertson, D.O. Claassen (Nashville, TN, USA)

    Objective: To describe adverse behavioral symptoms attributed to droxidopa therapy for neurogenic orthostatic hypotension (nOH). Background: Droxidopa, a norepinephrine (NE) precursor, improves symptoms of neurogenic…
  • 2016 International Congress

    Prevalence of orthostatic hypotension after a low subacute levodopa dose in patients with parkinsonism

    G. Calandra-Buonaura, L. Sambati, I. Gessaroli, A. Turrini, R. Terlizzi, G. Giannini, P. Guaraldi, P. Cortelli (Bologna, Italy)

    Objective: To evaluate the prevalence of orthostatic hypotension (OH) after a low subacute levodopa (LD) dose in patients with diagnosis of Parkinson's disease (PD) or…
  • 2016 International Congress

    Use of nicotine gum to treat acute low blood pressure in Parkinson’s disease

    J. DiFrancisco-Donoghue, A. Leder, M.K. Jung, W.G. Werner (Old Westbury, NY, USA)

    Objective: To evaluate (1) how nicotine chewing gum is tolerated (2) how nicotine chewing gum affects acute low blood pressure (BP) in Parkinson's disease (PD).…
  • 2016 International Congress

    Effects of pyridostigmine bromide vs. fludrocortison in the treatment of orthostatic hypotension in Parkinson’s disease

    S.R. Schreglmann, F. Büchele, M. Sommerauer, L. Epprecht, G. Kägi, S. Hägele-Link, O. Götze, L. Zimmerli, D. Waldvogel, C.R. Baumann (London, United Kingdom)

    Objective: To report results of an investigator-initiated trial to show the non-inferiority of pyridostigmine bromide (PB) vs. fludrocortisone (FC) in the treatment of symptomatic orthostatic…
  • 2016 International Congress

    The relationship between blood pressure, sex and survival in multiple system atrophy

    T. Gurevich, A. Fisher, L. Markin, A. Rozenberg, E. Atanasova Mishkova- Serafimova, D. Klepikov, A. Ezra, J. Knaani, N. Giladi, C. Peretz (Tel Aviv, Israel)

    Objective: To investigate the effect of BP parameters on survival in MSA patients by MSA type and sex. Background: Multiple system atrophy (MSA) is a…
  • 2016 International Congress

    Cerebral vasoreactivity in Parkinson’s disease and multiple system atrophy: A pilot study

    E. Indelicato, F.E. Pontieri, D. Benincasa, A. Fanciulli, F. Orzi, M. Giovannelli, G. Sette (Rome, Italy)

    Objective: To compare cerebral vasoreactivity in Parkinson´s disease (PD) and multiple system atrophy (MSA) patients with or without cardiovascular autonomic failure (CAF). Background: CAF is…
  • 2016 International Congress

    Orthostatic intolerance and falls in Parkinson’s disease

    A. Fanciulli, C. Dallinger, G. Goebel, R. Granata, S. Duerr, F. Sprenger, F. Krismer, C. Mueller, S. Boesch, M. Nocker, C. Scherfler, K. Seppi, W. Poewe, G.K. Wenning (Innsbruck, Austria)

    Objective: Primary objective: to assess the relationship between falls, orthostatic intolerance and orthostatic hypotension (OH) in patients with Parkinson's disease (PD). Secondary objective: to assess…
  • 2016 International Congress

    RBD increase non-motor symptom in Parkinson’s disease

    Y. Wu, Y. Liu, X. Zhu, X. Zhang, S. Kuo, W.G. Ondo (Shanghai, People's Republic of China)

    Objective: To investigate the relationship between the RBD and other non-motor symptoms in Parkinson's disase. Background: Rapid eye movement sleep behavior disorder (RBD) is frequent…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley